Citations

Clear

58 citation(s) found for "Robles, R".

Learning Curves and Complexity Evolution in Robotic Liver Surgery
Kuemmerli, Christoph , Hess, Gabriel Fridolin , Billeter, Adrian T. , Benedetto, Fabrizio Di , Odorizzi, Roberta, Sucandy, Iswanto , Aegerter, Noa L. E., Berchtold, Caroline , Bernardi, L. , Cristaudi, Alessandra , Balzano, E , Koh, Ye-Xin, Lin, Charles Chung-Wei, Fukumori, Daisuke , Tschuor, Christoph , White, Steve, Kroge, P Von, Heumann, Asmus , Meyere, Céline De, D’hondt, M, Haak, Fabian, Stättner, Stefan, Primavesi, Florian, Morgül, Haluk , Andreou, A, Ratti, F, Esquer, Ignacio Sánchez, Robles-Campos, Ricardo, Lopez-Lopez, Victor, Wakabayashi, Go , Nebbia, Martina, Rahbari, Nuh N., Ferretti, Stefano, Ettore, Giuseppe , Croner, RS , Dong, Y, Starlinger, P, Nickel, F, Müller, Beat P., Hess, Gabriel F , Guidetti, Cristiano , di Benedetto, Fabrizio , Sucandy, Iswanto , Aegerter, Noa L E , Berchtold, Caroline , Bernardi, Lorenzo , Cristaudi, Alessandra , Balzano, Emanuele , Ghinolfi, Davide , Goh, Brian K P , Fukumori, Daisuke , Tschuor, Christoph , Pandanaboyana, Sanjay , De Meyere, Celine , Seehofer, Daniel , Esquer, Ignacio Sánchez , Müller, Philip C , Koh, Ye-Xin , Lin, Charles Chung-Wei, Tschuor, Christoph , Kroge, Philipp H. von , D’Hondt, Mathieu , Haak, Fabian , Stättner, Stefan , Primavesi, Florian , Ratti, Francesca , Robles-Campos, Ricardo, López‐López, Víctor , Wakabayashi, Taiga , Nebbia, Martina , Gilg, Stefan , Birgin, Emrullah , Ferretti, Stefano , Ettore, Giuseppe Maria, Rahimli, Mirhasan , Nickel, Felix , Müller-Stich, Beat Peter

Mayo Clinic

Annals of Surgery | June 17, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/sla.0000000000007123 | PMID 42307103 Get It

Objective: To evaluate the institutional learning curve of robotic liver resection (RLR), its association with surgical complexity and outcomes in an international multicenter cohort. Summary of Background Data: RLR is increasingly adopted worldwide, but the dynamics of the learning process and its impact on surgical outcomes remain poorly defined. Methods: This international, multicenter, retrospective cohort study included consecutive patients who underwent RLR between 06/2013 and 12/2024 across 22 expert centers. Based on the first 150 cases at each center, three phases were used to define the learning curve: operative time for competency, major complications for proficiency, and textbook outcome for mastery. Risk-adjusted generalized additive models were used to assess the learning process. Benchmark performance was compared to international reference values. Results: Among 2,331 patients, the most common indications were hepatocellular carcinoma (36%), benign lesions (23%) and colorectal liver metastases (21%). Operative time decreased after achieving competency (case #62), from 240 to 220 minutes ( P <0.001). Major morbidity reached a plateau during the proficiency phase (cases #63–138; 9% vs. 11%, P =0.144), while progression to mastery (cases #139–150) was associated with a higher rate of textbook outcome (76% vs. 87%, P =0.021). In contrast, conversion (5.1% vs. 4.9% vs. 2%), bile leak (4.0% vs. 5.3% vs. 3.8%), and 90-day mortality (0.7% vs. 0.9% vs. 0.9%) remained low and stable across all learning phases. Importantly, benchmark criteria for operative time, hospital stay, and textbook outcome were met across all complexity groups, including during the early learning phase. Conclusions: Robotic liver surgery shows progressive outcome improvement with early achievement of benchmark-level results and stable performance across increasing complexity. These findings indicate that, in experienced centers, RLR can be safely implemented and integrated into clinical practice, supporting its key role in modern hepatobiliary surgery.
L5 Motor Paresis and Foot Drop Following Herpes Zoster Reactivation: An Unusual Presentation and Diagnostic Challenge in an Immunocompetent Patient - A Case Report
Romero, Tachy V. Hernandez, Ahmad, Ridwan , Orasma, Carlos A. Ruiz, Carcamo, Zulma D Sosa , Elwasila, Sammer M , Munipalli, Bala , Iftikhar, Salma , Gonzalez, Hector A. Robles, Dimberg, Elliot L., Alvarado, Joan M Irizarry , Rosales, J. Calvo , Hernandez Romero, Tachy V, Sosa Carcamo, Zulma D, Robles Gonzalez, Hector A, Irizarry Alvarado, Joan M , Cardenas Rosales, Juan Carlos , Orasma, Carlos Ruiz

Mayo Clinic

Journal of Primary Care & Community Health | June 12, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.1177/21501319261460420 | PMID 42281305 Get It

This is the case of a 67-year-old immunocompetent Hispanic male residing in Mexico who presented with acute right lower back and right lateral thigh pain. Initial imaging was unremarkable. He later developed painful vesicular lesions on the right foot and buttock. He was diagnosed with herpes zoster and initiated acyclovir and gabapentin. Ten days later, he developed foot drop, leg weakness, and urinary incontinence. Magnetic resonance imaging (MRI) showed enhancement of the cauda equina, and electrodiagnostic studies demonstrated right lumbar polyradiculopathy. The patient improved significantly with pain medications and physical therapy. After 8 months of physical therapy, he demonstrated significant clinical improvement. This case highlights the uncommon presentation of motor involvement in herpes zoster and emphasizes the role of imaging and electrophysiology in guiding diagnosis and management.
“We are all Human Beings That Deserve the Same Opportunities as Everyone Else”: Immigrant Perspectives on Health in Southeast Minnesota: A Photovoice Study
Lohr, Abby M. , Vargas-Robles, Jazlyn, Asiedu, Gladys B. , Ahmed, Yahye, Dirie, Hana, Molina, Luz, Capetillo, Graciela Porraz, Schachter, Josh, Porraz Capetillo, Graciela, Wieland, Mark L. , Sia, Irene G.

Mayo Clinic

Health Promotion Practice | March 31, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15248399261429976 | PMID 41913647 Get It

Due to systemic barriers, policymakers in the United States may be unaware of immigrants’ health-related priorities. In response, Rochester Healthy Community Partnership, a 22-year community-engaged partnership, collaborated with 14 Hispanic/Latino and Somali immigrant health promoters in fall 2023 using Photovoice to document their health-related assets and needs. After taking photos, the health promoters reflected, discussed the issues revealed in their images, and developed policy recommendations. Guided by Public Health Critical Race Praxis, we used thematic analysis to analyze health promoters’ reflections. Three themes emerged: healthy choices, inclusion of people and cultural celebrations, and access to opportunity. Health promoters want to expand healthy choices in Southeast Minnesota by growing community garden programming, protecting the environment, making healthy options accessible, and opening an affordable gym. They highlighted the importance of integrating culture and community into youth education, access to culturally appropriate foods, and the need to address Islamophobia. Health promoters wanted increased access to job opportunities, affordable housing, and health care. They saw these opportunities as vehicles for self-improvement but emphasized time management as essential in the United States. Ensuring that immigrants have a meaningful voice in shaping policies that affect health is critical. Policymakers can leverage these findings by demonstrating responsiveness to community-identified priorities and acting on health promoters’ policy recommendations. We encourage future Photovoice researchers to apply explicitly anti-racist frameworks, such as Public Health Critical Race Praxis, to document and challenge systemic oppression.
Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study
Arnold, Suzanne V., Spertus, John, Gosch, Kensey , Dunlay, S., Olds, Danielle , Jones, Philip G. , Kar, Saibal , Wu, Changfu, Cohen, David J., Cohen, David J. , Spertus, John A. , Dunlay, Shannon M. , Kar, Saibal , Arnold, Suzanne V. , Arnold, Suzanne V , Spertus, John A , Dunlay, Shannon , Olds, Danielle M , Cohen, David Jonathan , Gosch, Kensey

Mayo Clinic

Circulation | February 2, 2026 | Volume: 153 | Issue: 5 | Pages: 310-318

10.1161/circulationaha.125.076542 | PMID 41628259 Get It

BACKGROUND: Recent randomized trials have demonstrated that for patients with severe tricuspid regurgitation (TR), transcatheter tricuspid valve interventions (TTVI) improve patients’ symptoms, function, and quality of life and that the amount of health status improvement correlates with the extent of TR reduction. Defining this relationship in greater detail can potentially provide insight into device selection and patient-specific treatment goals. We therefore sought to better understand the relationship between both baseline TR severity and change in TR after TTVI and the extent of improvement in health status after TTVI. METHODS: As part of the Tri-QOL (Kansas City Cardiomyopathy Questionnaire Validation in Tricuspid Valve Disease) study, data from 11 studies of TTVI devices were transferred to the US Food and Drug Administration to harmonize and anonymize before analysis by an independent center. This secondary, observational analysis used patient-level data from the 6 single-arm studies of patients who underwent TTVI to explore the association of change in KCCQ-OS with TR grade using multivariable models, adjusted for age, sex, chronic lung disease, and baseline KCCQ-OS. The primary model included TR grade at baseline, TR grade at 1 month, and the interaction between the two. RESULTS: Among 1056 patients with ≥severe TR who underwent TTVI, mean age was 79.1±7.1 years, 60.3% were female, and mean baseline Kansas City Cardiomyopathy Questionnaire-overall summary score [KCCQ-OS] was 49.5±22.3. Baseline TR grade was severe in 33.5%, massive in 35.9%, and torrential in 30.6%. One-month after TTVI, TR was none/trace in 21.7%, mild in 27.2%, moderate in 28.1%, and ≥evere in 23.1%, while the mean change in KCCQ-OS was 17.0±21.3 points. In a multivariable model that included TR grade at baseline, TR grade at 1 month, and their interaction, there was a strong association between reduction in TR and improvement in KCCQ-OS, with no consistent evidence of a threshold of TR grade below which there was no further improvement in KCCQ-OS. However, among patients with baseline torrential TR, the extent of health status improvement plateaued for patients achieving moderate or less TR at 1 month (ie, a 3-grade improvement from baseline). CONCLUSIONS: Health status improvement after TTVI was most strongly associated with the degree of TR reduction, although there was minimal additional improvement for most patients beyond a 3-grade reduction in TR. These findings support the goal of achieving mild or less TR with TTVI, although patients with torrential TR at baseline may be well served if moderate TR can be achieved.
Selection of the Most Appropriate Radiation Treatment Modality for Children's Cancers: A Paediatric Radiation Oncology Society (PROS) Position Paper on the Ethical Utilization of Proton Therapy
Indelicato, Daniel J. , Mahajan, Anita , Parkes, Jeannette , Paulino, Arnold C. , Beljoudi, Guillaume, Kristensen, Ingrid, Lassen, Yasmin, Njiraini, Pauline Njoki , Qureshi, Bilal Mazhar , Robles, Beatriz Garcia, Seiersen, Klaus , Esiashvili, Natia , Indelicato, Daniel J , Parkes, Jeannette , Paulino, Arnold C , Njiraini, Pauline Njoki , Qureshi, Bilal Mazhar , Gaze, Mark N , Laprie, Anne , Robles, Beatriz Garcia, Timmermann, Beate , Gaze, Mark N.

Mayo Clinic

Pediatric Blood & Cancer | November 20, 2025 | Volume: 73 | Issue: 2 | Pages: No page available

10.1002/pbc.32155 | PMID 41261937 Get It

ABSTRACT Background Proton beam therapy (PBT) offers dosimetric advantages in pediatric radiotherapy by reducing radiation exposure to healthy tissues. However, broad implementation raises important ethical, logistical, and equity considerations, especially in settings with limited access to advanced technologies. Procedure This position paper by the Paediatric Radiation Oncology Society (PROS) reviews the clinical rationale for selecting radiotherapy modalities in children, with a specific focus on ethical utilization of PBT. The document synthesizes evidence on the benefits and limitations of modern photon and proton therapies, explores disparities in access, outlines the role of local pediatric radiation oncologists, and addresses the impact of industry‐driven messaging on family decision‐making. Results While PBT offers clinical benefit in selecting pediatric cancers, high‐quality photon‐based treatments such as IMRT and VMAT remain effective and widely accessible alternatives. The referral and evaluation process for PBT is complex and may introduce treatment delays. Travel and financial burdens can exacerbate disparities. PROS underscores the critical role of local pediatric radiation oncologists in counseling families, and calls for balanced, evidence‐based communication from providers and industry stakeholders. Conclusions PROS advocates for an ethical, equitable, and evidence‐informed approach to radiotherapy modality selection in children, reflecting holistic considerations beyond dosimetry. Proton therapy should be pursued when clinically indicated and accessible without compromising timely care. Investment in a comprehensive radiation therapy infrastructure, including professional education, collaborative research, and responsible public messaging, is essential to optimize pediatric cancer outcomes globally.
Systemic mRNA vaccines elicit rapid immune activation in canine brain tumors
Aghaee, Mahya , Qdaisat, Sadeem, Weidert, Frances, Garcia, Gabriel , Fagman, Lana, Stover, Brian, Moor, Rachel S F, Goldenberg, Eden, Chardon‐Robles, Jonathan, Elliott, Leighton , Foster, Timothy P. , Rahman, Maryam, Ghiaseddin, Ashley , Castillo, Paul , Lee, Ji‐Hyun , Doty, Andria , Milner, Rowan J. , Mitchell, Duane A. , Méndez-Gómez, Héctor , Carrera-Justiz, Sheila , Aghaee, Mahya , Doonan, Bently , Deleyrolle, Loic P. , Ligon, John A , Milner, Rowan J , Moore, Helen , Sayour, Elias J , Zhang, Dingpeng , Moor, Rachel S F, Xie, Chao Lian , Goldenberg, Eden, Roemeling, Christina A. Von , Doonan, Bently P. , Sawyer, W. Gregory , Sahay, Bikash , Seligson, Nathan D. , Silver, Natalie L.

Mayo Clinic

Journal for ImmunoTherapy of Cancer | November 11, 2025 | Volume: 13 | Issue: 11 | Pages: e011817

10.1136/jitc-2025-011817 | PMID 41218853 Get It

Malignant glioma is considered invariably recalcitrant, thus necessitating development of new therapeutic approaches. Spontaneously arising canine glioma exhibits important molecular and pathological similarities to malignant pediatric glioma, making it an invaluable model for testing novel therapies. We evaluated safety and activity of RNA lipid particle aggregates (LPAs) designed to provoke cancer immunogenicity in 10 dogs with histologically confirmed glioma. Vaccine manufacturing was feasible in all subjects and generally well tolerated. Median survival time was 123 and 155 days in dogs receiving three (Group A) or four (Group B) vaccines, respectively; this was increased from historical reporting of subjects receiving palliative care. Responding animals had a robust cytokine response following infusions. In animals receiving non-specific RNA-LPAs, there was localization of messenger RNA (mRNA) payloads to the brain tumor microenvironment and a rapid shift in immunologic gene signatures consistent with a viral response. These data demonstrate the ability to induce rapid viremic response in the tumor microenvironment following a single peripherally administered mRNA vaccine. Since RNA-LPAs are amenable to repeat boosts, these formulations may overcome challenges of tumor immunosuppression and therapeutic access and are currently under evaluation in first-in-human trials ( NCT04573140 , NCT06389591 ).
Selection of the Most Appropriate Radiation Treatment Modality for Children’s Cancers: A Paediatric Radiation Oncology Society (PROS) Position Paper on the Ethical Utilization of Proton Therapy
Indelicato, Daniel J. , Mahajan, Anita , Parkes, Jeannette , Paulino, Arnold C. , Beldjoudi, Guillaume , Kristensen, Ingrid, Lassen–Ramshad, Yasmin , Njiraini, Pauline Njoki , Robles, Beatriz García, Seiersen, Klaus , Paulino, Arnold C , Parkes, Jeannette , Indelicato, Daniel J , Njiraini, Pauline Njoki , Esiashvili, Natia , Beljoudi, Guillaume, Laprie, Anne , Lassen, Yasmin, Qureshi, Bilal Mazhar , Robles, Beatriz Garcia, Timmermann, Beate , Gaze, Mark N.

Mayo Clinic

No container title available | October 8, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.175992134.44586481/v1 Get It

Gastro-Entero-Colic Fistula After Successful EUS Guided Gastroenterostomy
Ladd, Antonio Mendoza , Ladna, Michel, Pecha, Luke, Sharzehi, Kaveh , Bhardwaj, Meera., Vargas, Jorge, Gutierrez, Olaya I. Brewer , Schlag, Christoph , Hindryckx, Pieter , Hucl, Tomáš , Sethi, Amrita , Masaryk, Viliam , Khara, Harshit S. , Mendoza Ladd, Antonio , Pérez‐Cuadrado‐Robles, Enrique , Han, Samuel , Vargas, Jorge, Inamdar, Sumant , Pham, Khanh Do-Cong

Mayo Clinic

Journal of Clinical Gastroenterology | July 21, 2025 | Volume: 60 | Issue: 6 | Pages: 543-548

10.1097/mcg.0000000000002178 | PMID 40689823 Get It

Background: EUS-guided gastroenterostomy (EUS-GE) is an effective option for the management of gastric outlet obstruction (GOO). Due to the poor prognosis of patients undergoing it, data on its long-term adverse events (AE) is scarce. Herein, we describe a cohort of patients with gastro-entero-colic fistula (GECF) as a late AE of previously successful EUS-GE. Methods: Patients who developed a GECF after EUS-GE from 10 high-volume centers were analyzed. Information collected included demographic characteristics, indications, clinical and technical success rates, stent type and size, fistula characteristics, management, and outcomes. Results: Sixteen cases were identified. The mean interval from index EUS-GE to the diagnosis of GECF was 4 to 8 weeks. The most common cause of GOO was pancreatic adenocarcinoma (PDAC). The transverse colon was the most common site for the GECF (14 patients). A 20×10 mm lumen apposing metal stent (LAMS) was utilized in 10 patients. Endoscopic management with a variety of modalities was successful in 13 cases. Follow-up interval after endoscopic management of the fistula averaged 2 to 4 weeks. At the time of the manuscript elaboration, 10 patients had died, 5 were alive, and 1 was lost to follow-up. Conclusions: This is the first description of a cohort of patients with GECF after EUS-GE. The exact mechanisms leading to GECF in these cases are unknown. Possible explanations include inadvertent colon puncture during the index procedure and/or entrapment of mesocolon. More data is needed to further characterize this AE.